Cargando…

Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria

OBJECTIVE: To assess the cost-effectiveness of a non-pneumatic anti-shock garment (NASG) for obstetric hemorrhage in tertiary hospitals in Egypt and Nigeria. METHODS: We combined published data from pre-intervention/NASG-intervention clinical trials with costs from study sites. For each country, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutherland, Tori, Downing, Janelle, Miller, Suellen, Bishai, David M., Butrick, Elizabeth, Fathalla, Mohamed M. F., Mourad-Youssif, Mohammed, Ojengbede, Oladosu, Nsima, David, Kahn, James G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640005/
https://www.ncbi.nlm.nih.gov/pubmed/23646124
http://dx.doi.org/10.1371/journal.pone.0062282
_version_ 1782476038095241216
author Sutherland, Tori
Downing, Janelle
Miller, Suellen
Bishai, David M.
Butrick, Elizabeth
Fathalla, Mohamed M. F.
Mourad-Youssif, Mohammed
Ojengbede, Oladosu
Nsima, David
Kahn, James G.
author_facet Sutherland, Tori
Downing, Janelle
Miller, Suellen
Bishai, David M.
Butrick, Elizabeth
Fathalla, Mohamed M. F.
Mourad-Youssif, Mohammed
Ojengbede, Oladosu
Nsima, David
Kahn, James G.
author_sort Sutherland, Tori
collection PubMed
description OBJECTIVE: To assess the cost-effectiveness of a non-pneumatic anti-shock garment (NASG) for obstetric hemorrhage in tertiary hospitals in Egypt and Nigeria. METHODS: We combined published data from pre-intervention/NASG-intervention clinical trials with costs from study sites. For each country, we used observed proportions of initial shock level (mild: mean arterial pressure [MAP] >60 mmHg; severe: MAP ≤60 mmHg) to define a standard population of 1,000 women presenting in shock. We examined three intervention scenarios: no women in shock receive the NASG, only women in severe shock receive the NASG, and all women in shock receive the NASG. Clinical data included frequencies of adverse health outcomes (mortality, severe morbidity, severe anemia), and interventions to manage bleeding (uterotonics, blood transfusions, hysterectomies). Costs (in 2010 international dollars) included the NASG, training, and clinical interventions. We compared costs and disability-adjusted life years (DALYs) across the intervention scenarios. RESULTS: For 1000 women presenting in shock, providing the NASG to those in severe shock results in decreased mortality and morbidity, which averts 357 DALYs in Egypt and 2,063 DALYs in Nigeria. Differences in use of interventions result in net savings of $9,489 in Egypt (primarily due to reduced transfusions) and net costs of $6,460 in Nigeria, with a cost per DALY averted of $3.13. Results of providing the NASG for women in mild shock has smaller and uncertain effects due to few clinical events in this data set. CONCLUSION: Using the NASG for women in severe shock resulted in markedly improved health outcomes (2–2.9 DALYs averted per woman, primarily due to reduced mortality), with net savings or extremely low cost per DALY averted. This suggests that in resource-limited settings, the NASG is a very cost-effective intervention for women in severe hypovolemic shock. The effects of the NASG for mild shock are less certain.
format Online
Article
Text
id pubmed-3640005
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36400052013-05-03 Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria Sutherland, Tori Downing, Janelle Miller, Suellen Bishai, David M. Butrick, Elizabeth Fathalla, Mohamed M. F. Mourad-Youssif, Mohammed Ojengbede, Oladosu Nsima, David Kahn, James G. PLoS One Research Article OBJECTIVE: To assess the cost-effectiveness of a non-pneumatic anti-shock garment (NASG) for obstetric hemorrhage in tertiary hospitals in Egypt and Nigeria. METHODS: We combined published data from pre-intervention/NASG-intervention clinical trials with costs from study sites. For each country, we used observed proportions of initial shock level (mild: mean arterial pressure [MAP] >60 mmHg; severe: MAP ≤60 mmHg) to define a standard population of 1,000 women presenting in shock. We examined three intervention scenarios: no women in shock receive the NASG, only women in severe shock receive the NASG, and all women in shock receive the NASG. Clinical data included frequencies of adverse health outcomes (mortality, severe morbidity, severe anemia), and interventions to manage bleeding (uterotonics, blood transfusions, hysterectomies). Costs (in 2010 international dollars) included the NASG, training, and clinical interventions. We compared costs and disability-adjusted life years (DALYs) across the intervention scenarios. RESULTS: For 1000 women presenting in shock, providing the NASG to those in severe shock results in decreased mortality and morbidity, which averts 357 DALYs in Egypt and 2,063 DALYs in Nigeria. Differences in use of interventions result in net savings of $9,489 in Egypt (primarily due to reduced transfusions) and net costs of $6,460 in Nigeria, with a cost per DALY averted of $3.13. Results of providing the NASG for women in mild shock has smaller and uncertain effects due to few clinical events in this data set. CONCLUSION: Using the NASG for women in severe shock resulted in markedly improved health outcomes (2–2.9 DALYs averted per woman, primarily due to reduced mortality), with net savings or extremely low cost per DALY averted. This suggests that in resource-limited settings, the NASG is a very cost-effective intervention for women in severe hypovolemic shock. The effects of the NASG for mild shock are less certain. Public Library of Science 2013-04-30 /pmc/articles/PMC3640005/ /pubmed/23646124 http://dx.doi.org/10.1371/journal.pone.0062282 Text en © 2013 Sutherland et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Sutherland, Tori
Downing, Janelle
Miller, Suellen
Bishai, David M.
Butrick, Elizabeth
Fathalla, Mohamed M. F.
Mourad-Youssif, Mohammed
Ojengbede, Oladosu
Nsima, David
Kahn, James G.
Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria
title Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria
title_full Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria
title_fullStr Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria
title_full_unstemmed Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria
title_short Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria
title_sort use of the non-pneumatic anti-shock garment (nasg) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in egypt and nigeria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640005/
https://www.ncbi.nlm.nih.gov/pubmed/23646124
http://dx.doi.org/10.1371/journal.pone.0062282
work_keys_str_mv AT sutherlandtori useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria
AT downingjanelle useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria
AT millersuellen useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria
AT bishaidavidm useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria
AT butrickelizabeth useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria
AT fathallamohamedmf useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria
AT mouradyoussifmohammed useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria
AT ojengbedeoladosu useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria
AT nsimadavid useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria
AT kahnjamesg useofthenonpneumaticantishockgarmentnasgforlifethreateningobstetrichemorrhageacosteffectivenessanalysisinegyptandnigeria